Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Becobank-Forte is a branded generic multivitamin supplement developed and marketed by Tabq Therapeutics. The formulation typically consists of a high-potency B-complex (including thiamine, riboflavin, niacinamide, calcium pantothenate, pyridoxine, biotin, folic acid, and cyanocobalamin) combined with Vitamin C (ascorbic acid). These vitamins serve as essential cofactors for a wide range of metabolic enzymes involved in energy production, DNA synthesis, and the maintenance of the nervous and immune systems. Becobank-Forte is indicated for the prevention and treatment of vitamin deficiencies, particularly during periods of increased nutritional requirement, recovery from illness, or chronic stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Becobank-Forte.